Alpha-2 macroglobulin for the treatment of neuroma pain in the stump of a below-knee amputee patient.

alpha-2 macroglobulin interventional pain medicine neuroma neuropathy pain medicine regenerative medicine stem cell ultrasound ultrasound-guided ultrasound-guided intervention

Journal

Pain management
ISSN: 1758-1877
Titre abrégé: Pain Manag
Pays: England
ID NLM: 101555934

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 22 8 2023
pubmed: 8 8 2023
entrez: 8 8 2023
Statut: ppublish

Résumé

This case report describes the successful treatment of neuroma pain in the setting of below knee amputations using alpha-2-macroglobulin (A2M). A 34-year-old female patient presented with 9 months of stump pain despite conservative treatment. The exam revealed persistent pain through rest periods and weight-bearing status during therapy. Ultrasound showed neuroma formation with neovascularization. The patient underwent two A2M hydrodissection treatments, 2 weeks apart. The patient reported significant pain relief. Ultrasound showed decreases in neovascularization and cross-sectional area of the neuroma. The patient was able to ambulate pain-free for 2 years and reported no pain since. A2M may be a treatment for patients with neuroma pain in the setting of amputations.

Identifiants

pubmed: 37551540
doi: 10.2217/pmt-2023-0005
doi:

Substances chimiques

Pregnancy-Associated alpha 2-Macroglobulins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-341

Auteurs

Jeimylo C de Castro (JC)

SMARTMD Center for Non-Surgical Pain Interventions, Makati, Philippines.

Daniel Wang (D)

MedStar Health, Baltimore, MD, 21218, USA.

Jeffrey Strakowski (J)

The Ohio State University, Department of Physical Medicine & Rehabilitation, Columbus, OH, 43214, USA.

Dessy R Emril (DR)

Medical Faculty of Universitas Syiah Kuala, Aceh, Indonesia.

George C Chang Chien (GC)

Pain Management, Ventura County Medical Center, CA, 93003 USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH